Progranulin-dependent expression of adenosine triphosphate–dependent binding cassette (ABC)B5 drug transporter is likely the potential molecular mechanism by which progranulin promotes tumor cell resistance to platinum-based and doxorubicin drugs [143]. The gene discussed is GRN; the disease is neoplasm.